UK Renal Registry, Bristol, UK.
Nephron Clin Pract. 2013;123 Suppl 1:1-28. doi: 10.1159/000353320. Epub 2013 Jun 10.
This chapter describes the characteristics of adult patients starting renal replacement therapy (RRT) in the UK in 2011 and the incidence rates for RRT in Primary Care Trusts and Health Boards (PCT/HBs) in the UK.
Basic demographic and clinical characteristics are reported on patients starting RRT at all UK renal centres. Presentation time, defined as time between first being seen by a nephrologist and start of RRT, was also studied. Age and gender standardised ratios for incidence rates in PCT/HBs were also calculated.
In 2011, the incidence rate in the UK was similar to 2010 at 108 per million population (pmp). There were wide variations between PCT/HBs in standardised incidence ratios. For the 2006-2011 incident cohort analysis the range was 0.42 to 2.52 (IQR 0.85, 1.20). The median age of all incident patients was 64.9 years (IQR 50.9, 75.1). For transplant centres this was 63.8 years (IQR 49.5, 74.3) and for non-transplanting centres 66.2 years (IQR 52.4, 76.0). The median age for non-Whites was 58.4 years. Diabetic renal disease remained the single most common cause of renal failure (25%). By 90 days, 67.1% of patients were on haemodialysis, 19.2% on perito- neal dialysis, 7.8% had had a transplant and 5.8% had died or stopped treatment. This is the second year in a row that the percentage on peritoneal dialysis has increased and, in 2011, this was most notable in the 65-74 age group. There was a lot of variability in use of PD with some centres having over twice the average percentage on PD. The mean eGFR at the start of RRT was 8.7 ml/min/1.73 m(2) similar to the previous four years. Late presentation (<90 days) fell from 23.9% in 2006 to 19.6% in 2011. There was no relationship between social deprivation and presentation pattern.
Incidence rates have plateaued in England over the last six years. There has been an increase in the percentage of new patients still on RRT at 90 days after starting who were on PD at 90 days (19.2 to 20.4%).
本章描述了 2011 年英国开始接受肾脏替代治疗(RRT)的成年患者的特征,以及英国初级保健信托基金和卫生委员会(PCT/HBs)的 RRT 发病率。
报告了所有英国肾脏中心开始接受 RRT 的患者的基本人口统计学和临床特征。还研究了就诊时间,定义为首次接受肾病医生就诊和开始 RRT 之间的时间。还计算了 PCT/HBs 发病率的年龄和性别标准化比值。
2011 年,英国的发病率与 2010 年相似,为每百万人口 108 人(pmp)。PCT/HBs 之间的标准化发病率比值存在很大差异。对于 2006-2011 年的发病队列分析,范围为 0.42 至 2.52(IQR 0.85,1.20)。所有新发病例患者的中位年龄为 64.9 岁(IQR 50.9,75.1)。对于移植中心,这一年龄为 63.8 岁(IQR 49.5,74.3),而非移植中心为 66.2 岁(IQR 52.4,76.0)。非白人的中位年龄为 58.4 岁。糖尿病肾病仍然是肾衰竭的最常见原因(25%)。90 天后,67.1%的患者接受血液透析,19.2%接受腹膜透析,7.8%接受移植,5.8%死亡或停止治疗。这是连续第二年腹膜透析的比例增加,2011 年,这在 65-74 岁年龄组中最为明显。腹膜透析的使用存在很大差异,有些中心腹膜透析的比例是平均水平的两倍多。开始 RRT 时的平均 eGFR 为 8.7 ml/min/1.73 m(2),与前四年相似。晚期就诊(<90 天)从 2006 年的 23.9%下降到 2011 年的 19.6%。社会贫困程度与就诊模式之间没有关系。
过去六年,英格兰的发病率已趋于稳定。开始接受 RRT 后 90 天仍在接受治疗的新患者中,90 天内接受 PD 治疗的比例有所增加(从 19.2%增加到 20.4%)。